PedAM
Pediatric Disease Annotations & Medicines
| Disease | dysphagia |
| Phenotype | C0014859|esophageal cancer |
| Sentences | 19 |
| PubMedID- 25789035 | A previous study conducted in multiple institutions determined that icrt may provide longer-term symptom improvement for cases of inoperable advanced esophageal cancer with dysphagia, compared with metallic stent placement (5). |
| PubMedID- 20859687 | Background: expandable esophageal stents are widely used for the palliation of dysphagia in patients with esophageal cancer and are also beginning to be used in patients with benign esophageal diseases such as refractory strictures and fistulas. |
| PubMedID- 26464685 | Objective: although the placement of esophageal self-expandable stents (ses) can effectively relieve dysphagia after radiotherapy in patients with esophageal cancer (ec), it may induce severe esophageal complications. |
| PubMedID- 20835926 | Study aim: to compare the duration of relief of dysphagia in patients with inoperable esophageal cancer treated with esophageal stenting alone or a combination of esophageal stenting and external beam radiotherapy (ebrt), and to assess overall survival, treatment-related complications, and quality of life (qol) in the two groups. |
| PubMedID- 21991527 | Brachytherapy has been found to palliate dysphagia effectively in patients with advanced esophageal cancer, providing a sustained improvement in dysphagia symptoms and quality of life over time. |
| PubMedID- 20538080 | Conclusion: jejunostomy feeding catheter provided nutritional access to oesophageal cancer patients with complete dysphagia using a locally prepared formula. |
| PubMedID- 24674161 | Purpose: palliative radiotherapy has traditionally been used as a noninvasive means of palliating dysphagia in patients with incurable esophageal cancer. |
| PubMedID- 20890057 | Esophageal stents for the treatment of malignant dysphagia in patients with esophageal cancer. |
| PubMedID- 21742654 | Objective: to retrospectively assess the efficacy and safety of palliative chemoradiotherapy in stage ivb esophageal cancer patients with dysphagia due to the primary lesion. |
| PubMedID- 23370813 | Radiological image-guided placement of covered niti-s stent for palliation of dysphagia in patients with cervical esophageal cancer. |
| PubMedID- 26045491 | We report tracheal-bronchial migration of a covered esophageal self-expanding metal stent used to relieve dysphagia in a patient with advanced esophageal cancer. |
| PubMedID- 26016143 | To control dysphagia 202 patients with a verified esophageal cancer of stage ct1-4n0-2m0-1 underwent intraluminal brachytherapy with neoadjuvant chemoradiotherapy in the process of combined radiation/chemoradiation therapy and palliative treatment. |
| PubMedID- 25598945 | First, if diagnosed early, the dysphagia resulted from a potential esophageal cancer may be attributed to dysphagia lusoria, and the patient may miss the appropriate treatment. |
| PubMedID- 24906258 | esophageal cancers rather present with dysphagia, odynophagia or systemic symptoms. |
| PubMedID- 19788439 | Self-expandable metal stents (sems) have been mostly reserved for palliation of dysphagia because of advanced esophageal cancer. |
| PubMedID- 22849981 | The problem pattern did not differ between disease groups apart from dysphagia in oesophageal cancer. |
| PubMedID- 26542798 | Hence, esophageal stenting is considered an option for esophageal cancer patients with severe dysphagia combined with a short life expectancy or recurrent tumor growth after cancer treatment [11]. |
| PubMedID- 20871187 | Some studies recommend the major procedure as a palliative measure for the relief of dysphagia in esophageal cancer not amenable to a complete clearance. |
| PubMedID- 22695208 | Patients: nineteen consecutive patients with significant dysphagia resulting from unresectable esophageal cancer, with a life expectancy of more than 3 months. |
Page: 1